cell morphology
Recently Published Documents


TOTAL DOCUMENTS

2409
(FIVE YEARS 460)

H-INDEX

93
(FIVE YEARS 9)

2022 ◽  
pp. 1-12
Author(s):  
Sule Canberk ◽  
Eleni Thodou ◽  
Massimo Bongiovanni

“Small-cell malignancies of thyroid” is an unsolved dilemma. This term represents an umbrella terminology in thyroid, encompassing for a small group of tumors in which some of them are well-recognized tumors like medullary thyroid carcinoma, poorly differentiated thyroid carcinoma, and primary thyroid lymphomas and teratoma, whereas the remaining are less known as primary neuroendocrine carcinoma of thyroid, primary extraskeletal Ewing family tumors, and adamantinoma-like Ewing sarcoma. When the issue comes to evaluate a cytological sample predominantly composed of small-cell morphology, metastatic small-cell carcinomas to thyroid also should be excluded. In this review, our group focused on the main cytomorphological and clinical clues of each entity that help to set up a correct differential diagnosis. The literature discussions were also included for the entities that are not yet recognized by the mother publication WHO. A key point of the issue’s simple algorithm based on FNAC with small-cell morphology of thyroid was suggested by the authors.


Author(s):  
Maxx Swoger ◽  
Sarthak Gupta ◽  
Elisabeth E. Charrier ◽  
Michael Bates ◽  
Heidi Hehnly ◽  
...  

Author(s):  
Alessandra Marconi ◽  
Marika Quadri ◽  
Francesca Farnetani ◽  
Silvana Ciardo ◽  
Elisabetta Palazzo ◽  
...  

Cornea ◽  
2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Clémence Bonnet ◽  
Tulika Chauhan ◽  
Erick Encampira Luna ◽  
Qihua Le ◽  
Chi-Hong Tseng ◽  
...  

Cells ◽  
2021 ◽  
Vol 10 (12) ◽  
pp. 3565
Author(s):  
Yiling Wang ◽  
Audrey Minden

P21-activated kinases (PAKs) are serine/threonine kinases involved in the regulation of cell survival, proliferation, inhibition of apoptosis, and the regulation of cell morphology. Some members of the PAK family are highly expressed in several types of cancer, and they have also been implicated in several other medical disorders. They are thus considered to be good targets for treatment of cancer and other diseases. Although there are several inhibitors of the PAKs, the utility of some of these inhibitors is reduced for several reasons, including limited metabolic stability. One way to overcome this problem is the use of nanoparticles, which have the potential to increase drug delivery. The overall goals of this review are to describe the roles for PAK kinases in cell signaling and disease, and to describe how the use of nanomedicine is a promising new method for administering PAK inhibitors for the purpose of disease treatment and research. We discuss some of the basic mechanisms behind nanomedicine technology, and we then describe how these techniques are being used to package and deliver PAK inhibitors.


2021 ◽  
Author(s):  
Yannik Severin ◽  
Benjamin D. Hale ◽  
Julien Mena ◽  
David Goslings ◽  
Beat M. Frey ◽  
...  

SummaryPhenotypic plasticity is essential to the immune system, yet the factors that shape it are not fully understood. Here, we comprehensively analyze immune cell phenotypes including morphology across human cohorts by single-round multiplexed immunofluorescence, automated microscopy, and deep learning. Using the uncertainty of convolutional neural networks to cluster the phenotypes of 8 distinct immune cell subsets, we find that the resulting maps are influenced by donor age, gender, and blood pressure, revealing distinct polarization and activation-associated phenotypes across immune cell classes. We further associate T-cell morphology to transcriptional state based on their joint donor variability, and validate an inflammation-associated polarized T-cell morphology, and an age-associated loss of mitochondria in CD4+ T-cells. Taken together, we show that immune cell phenotypes reflect both molecular and personal health information, opening new perspectives into the deep immune phenotyping of individual people in health and disease.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Patrick Stoiber ◽  
Pietro Scribani Rossi ◽  
Niranjana Pokharel ◽  
Jean-Luc Germany ◽  
Emily A. York ◽  
...  

AbstractFactor quinolinone inhibitors are promising anti-cancer compounds, initially characterized as specific inhibitors of the oncogenic transcription factor LSF (TFCP2). These compounds exert anti-proliferative activity at least in part by disrupting mitotic spindles. Herein, we report additional interphase consequences of the initial lead compound, FQI1, in two telomerase immortalized cell lines. Within minutes of FQI1 addition, the microtubule network is disrupted, resulting in a substantial, although not complete, depletion of microtubules as evidenced both by microtubule sedimentation assays and microscopy. Surprisingly, this microtubule breakdown is quickly followed by an increase in tubulin acetylation in the remaining microtubules. The sudden breakdown and partial depolymerization of the microtubule network precedes FQI1-induced morphological changes. These involve rapid reduction of cell spreading of interphase fetal hepatocytes and increase in circularity of retinal pigment epithelial cells. Microtubule depolymerization gives rise to FH-B cell compaction, as pretreatment with taxol prevents this morphological change. Finally, FQI1 decreases the rate and range of locomotion of interphase cells, supporting an impact of FQI1-induced microtubule breakdown on cell motility. Taken together, our results show that FQI1 interferes with microtubule-associated functions in interphase, specifically cell morphology and motility.


Sign in / Sign up

Export Citation Format

Share Document